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 Abstract  
  The production and certification of a series of azaspiracid (AZA) calibration 
solution reference materials is described. Azaspiracids were isolated from contaminated 
mussels, purified by preparative liquid chromatography and dried under vacuum to the 
anhydrous form. Purity was assessed by liquid chromatography–mass spectrometry (LC-
MS) and nuclear magnetic resonance (NMR) spectroscopy.  Final concentration of each 
AZA in a CD3OH stock solution was determined accurately by quantitative NMR 
spectroscopy.  This solution was then diluted very accurately in degassed, high purity 
methanol to a concentration of 1.47 ± 0.08 μmol/L for AZA1, 1.52  ± 0.05 μmol/L for 
AZA2, and 1.37  ± 0.13 μmol/L for AZA3.  Aliquots were dispensed into argon-filled 
glass ampoules, which were immediately flame-sealed. The calibration solutions are 
suitable for method development, method validation, calibration of liquid 
chromatography or mass spectrometry instrumentation and quality control of shellfish 
monitoring programs. 
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Introduction  
 Azaspiracids (AZAs) are a class of lipophilic polyether marine biotoxins that 
were first detected in harvested mussels (Mytilus edulis) from Killary Harbour on the 
west coast of Ireland in 1995. Symptoms resembling those of diarrhetic shellfish 
poisoning (DSP) were reported by those affected, including nausea, vomiting, stomach 
cramps, and severe diarrhea. A relationship between these incidents and a specific toxin 
could not be immediately determined because DSP and PSP toxins were only present in 
low levels and known toxin producing phytoplankton species were absent in the 
associated water samples [1, 2]. A new toxic compound was soon identified as the 
causative agent and provisionally named Killary toxin-3 (KT3) in recognition of the 
location where the mussels originated [3].  Following elucidation of the structure, it was 
renamed azaspiracid-1 (AZA1) [4]. AZAs possess a unique spiral ring assembly, a cyclic 
amine and a carboxylic acid group (Fig. 1). Shortly after the initial discovery of AZA1, 
two further analogs, 22-desmethylazaspiracid (AZA3) and 8-methylazaspiracid (AZA2) 
were discovered [5]. Subsequently, further hydroxylated analogues were discovered by 
the use of mass spectrometry [6]  To date, some 20 analogues are known, including 
dihydroxy, carboxy and carboxy-hydroxy-derivatives [7].  Azadinium spinosum has 
recently been identified as the producer [8, 9], while AZA3 is likely a product of 
metabolism in shellfish [10]. AZAs have since been found throughout the North and 
West of Europe [11-15] and have most recently been detected in mussels from Morocco 
[16].  
These compounds have a high oral toxicity to humans and have been responsible 
for incidents of shellfish poisoning [17].  AZAs can be found in various species of filter-
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feeding bivalve mollusks such as oysters, mussels, scallops, and clams.  Toxicological 
properties of this group of toxins are being studied to determine the maximum allowable 
levels in shellfish for human consumption. Due to the limited data available from many 
of the AZP events, nearly all information regarding AZA toxicology has been obtained 
from controlled in vitro and in vivo experiments [18-21].  Many of these efforts have 
been directed towards assessing the risk of AZA consumption in contaminated shellfish 
and in turn, identifying the molecular target(s) of AZA, which is currently unknown [22]. 
All symptoms observed in humans following consumption of shellfish contaminated with 
AZAs appear within hours of ingestion, and include nausea, vomiting, severe diarrhea 
and stomach cramps. The illness persists for 2-3 days and full recovery has been 
established in all cases during the incident in Arranmore Island, 1997 [23]. As of yet, no 
long term effects or illness have been reported. Azaspiracid poisoning (AZP) remains a 
rare illness, as only few intoxication events have been reported to date [17, 24]. Its 
similarity to ‘food poisoning’ or DSP and because the symptoms of the illness disappear 
rapidly (i.e., days) and are not fatal [14], more cases of AZP are thought to occur than are 
reported. Within the European Union, the maximum allowable level of AZAs in shellfish 
is 160 µg/Kg AZA equivalents [25]. This regulation specifically includes AZA1, -2, -3, 
as preliminary risk assessment suggested that low concentrations and low toxicities of 
other analogues do not necessitate a particular need to monitor these compounds [26]. 
Certified reference materials (CRMs) play a vital role in shellfish toxin 
monitoring programs as they facilitate method validation, ensure accuracy of results, and 
maintain consistency between laboratories.  CRMs are also essential for laboratories 
maintaining a quality assurance system such as ISO-17025 [27], as they ensure accuracy 
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and traceability to international standards.  However, shellfish toxin CRM availability is 
limited, generally due to insufficient quantities of the toxin of interest available for CRM 
production.  The complex structures of marine toxins do not allow for efficient synthetic 
production, thus naturally occurring sources are generally required for production.  The 
isolation of shellfish toxins from natural sources is not only labour-intensive, but 
generally yields relatively low quantities of purified toxin.  Working with such small 
quantities of material for CRM production presents a significant analytical challenge and 
specialized methodologies and advanced analytical instrumentation are essential.  These 
factors drastically increase the cost of producing a CRM, which has likely limited the 
widespread availability of shellfish toxin reference materials.                  
 In this report, the production and certification of a series of certified calibration 
solutions for azaspiracids-1, -2, and -3 will be described.  The workflow and 
methodologies employed make use of advanced analytical techniques, such as liquid 
chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) 
spectroscopy for characterization and quantification.  Major steps in the production and 
certification will be described [28-30] and parameters such as structural confirmation,  
purity assessment, homogeneity, stability, and final certified value assignments will be 
discussed.   
 
Experimental  
Chemicals  
  High purity methanol (MeOH) and ethanol (EtOH) from Burdick and Jackson 
(B&J) was used. Acetonitrile (ACN), ethyl acetate (EtOAc) and hexane were purchased 
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from Caledon and were of high purity (distilled in glass). Formic acid (99.9% purity) and 
caffeine (USP grade) were acquired from Sigma Aldrich. Reagent quality glacial acetic 
acid was purchased from Caledon. Ammonium formate was obtained from Merck. D3 
Methanol (D3, 99.5%) was purchased from Cambridge Isoptope Laboratories (CIL).   
 
Source of the material and isolation of AZAs 
 AZAs were isolated from the hepatopancreas (HP) tissue of contaminated blue 
mussels (Mytilus edulis) originating from Bruckless, Co. Donegal, Ireland, which were 
harvested in August 2005. Portions of HP tissue (0.5 kg) were extracted 3 times with 300 
mL of 95% EtOH (Fig. 2). The mixture was centrifuged (2000 g’s for 20 min) and the 
ethanolic  supernatant was evaporated to dryness using rotary evaporator (Büchi) 
equipped with a dry-ice/acetone-cooled coldfinger. The dry residue was partitioned 
between EtOAc (300 mL) and 1M NaCl (100 mL). The aqueous phase was re-extracted 
two additional times with 300 mL of EtOAc. The organic layers were combined and 
taken to dryness  using a rotary evaporator equipped with a dry-ice/acetone-cooled 
coldfinger.  
 The dried EtOAc extract was taken up in equal volumes (200 mL) of hexane and 
80/20 v/v MeOH/water. The aqueous phase was collected and the hexane phase re-
extracted with a further 200 mL of 80/20 v/v MeOH/water.  The aqueous MeOH portions 
were combined, evaporated to dryness, pre-absorbed onto silica gel (Sigma, 10-40 μm, 
Type H, No Binder) using EtOAc and then applied onto a silica gel (Sigma, 10-40 μm, 
Type H, No Binder) column (5 cm i.d. x 6.5 cm). The column was eluted using a 
stepwise gradient with equal amounts (300 mL) of hexane, EtOAc, 90/10 v/v 
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EtOAc/MeOH 70/30 v/v EtOAc/MeOH, 50/50 v/v EtOAc/MeOH and MeOH using 
vacuum (Fraction 1-6 respectively). All eluents apart from hexane contained 0.1% acetic 
acid. Fraction 4 (70% EtOAc) was dried and applied to a open glass column (1.6 cm x 81 
cm) packed with Sephadex LH-20 (Amersham Biosciences) and eluted with MeOH with 
gravity flow. A total of 70 fractions (1.5 mL) were collected. Fractions 52-59 were 
combined, evaporated to dryness, dissolved in MeOH (1.5 mL) and applied onto a flash 
column (1 cm x 21 cm) packed with C8-silica (LiChroPrep, C8, Merck, 25-40 μm). A 
step gradient elution was performed with 50/50 v/v ACN/water, 60/40 v/v ACN/water, 
70/30 v/v ACN/water and 100% ACN, all of which contained 0.1% acetic acid. Again a 
total of 70 fractions were collected (70 drops per fraction). Fractions 14-22 were 
combined, the solvent evaporated and the sample dissolved in 200 μL of MeOH.  
 Final purification of AZAs was carried out on C8-silica HPLC column 
(Phenomenex Luna, 10 mm i.d. x 250 mm) using 50/50 v/v ACN/water with 1 mM 
ammonium formate and 0.05% formic acid at a flow rate of 5 mL/min. Mass-directed 
fraction collection was used to collect the eluting toxin on an Agilent 1100 HPLC system 
coupled to an Agilent MSD single quadrupole mass spectrometer (1946 series) with an 
active splitter device (Agilent). The active splitting ratio was set to 500:1. The organic 
solvent was evaporated and the remaining aqueous solution was partitioned with high 
purity EtOAc to remove formic acid and ammonium formate from the purified AZAs. 
The organic phase was evaporated to dryness, re-dissolved in 700 µL CD3OH and then 
transferred into a Wilmad 535-PP NMR tube.  
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Recovery quantitation 
Recovery of toxin from the individual isolation steps was measured by LC-MS, 
using an API 165 single quadrupole mass spectrometer (MDS Sciex). Separation of the 
toxins was achieved on a Hypersil BDS C8 column (2.1 mm i.d. x 5 cm, 3 µm) using 
isocratic flow of 70% B where A was H2O and B was 95% ACN, both containing 2 mM 
ammonium formate and 40 mM formic acid. The flow rate was 200 µL/min.  
 
Structural confirmation  
The molecular structures of AZA-1,-2 and -3 were confirmed by NMR 
spectroscopy and quadrupole/time-of-flight (Q-ToF) mass spectrometry using a Waters 
QToF Premier (Milford, MA, USA). For accurate mass determinations, appropriate 
dilutions of each toxin were carried out using MeOH and were then infused at a rate of 5-
10 µL/min into the QToF mass spectrometer.  
 
Purity assessment by LC-MS 
Purity analysis by LC-MS was carried out on API 165 MS coupled to an Agilent 
1100 series HPLC. A gradient elution was performed using H2O (A) and 95% ACN (B), 
both containing 2 mM ammonium formate and 40 mM formic acid, running from 10% B 
to 100% B in 20 min and holding at 100% B for 20 min. Chromatography was performed 
on a Hypersil BDS C8 column (2 mm i.d. x 150 mm, 3 µm, Keystone) at a flow rate of 
200 µL/min. The column temperature was set to 25°C. The MS scan range was set from 
m/z 600 to m/z 1000.  
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Contamination from other analogs of the toxin was assessed using an isocratic run on the 
same system. Mobile phase was 70% B and 30% A, at 200 µL/min on the same column. 
The MS was set to monitor for the [M+H]+ ions of the three main AZAs, m/z 828.5 
(AZA3), m/z 842.5 (AZA1) and m/z 856.5 (AZA2) as well as m/z 810.5 (AZA25) [7]. 
 
Purity assessment by NMR 
One dimensional 1H NMR spectroscopy was employed to assess the purity of the 
AZAs.  The sample was dissolved in 700 μL of CD3OH and transferred to a high 
precision 5 mm NMR tube (Wilmad 535-PP).  The 1H spectrum was acquired with single 
frequency presaturation on resonance with the −OH resonance from the MeOH solvent 
set to the center of the spectrum.  The presaturation power was set to 55 dB attenuation 
down from 50 W (approx. 100 mw) and was applied during the relaxation delay of 2 s.  
The spectrum at 500.13 MHz was acquired with a Bruker DRX-500 spectrometer using a 
90o pulse of approximately 6.4 μs over a sweep width of 7507 Hz (15 ppm at 500 MHz) 
into 32K points for an acquisition time of 2.18 s.  A total of 128 scans were acquired to 
ensure adequate signal-to-noise of any impurity peaks.  The spectrum was Fourier 
Transformed after zero filling to 64K points and applying an exponential window 
function with a line broadening parameter of 0.3 Hz.  The spectrum was then phased to 
pure absorption mode. 
 
Quantification by NMR 
Quantification of AZAs was performed on three replicate aliquots of the stock 
solution dissolved in CD3OH using previously published QNMR methodology [31]. The 
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aliquots were run against three external standards of caffeine dissolved in H2O at a 
concentration of 4.10 mM.  All samples were run in 5 mm high-precision NMR tubes 
(Wilmad 535-PP) at 20°C using 90° pulses and 15 s relaxation delays with continuous 
wave presaturation of the protonated solvent resonance at 55 dB attenuation down from 
50W during the relaxation delay.  The receiver gain was kept constant over all of the 
samples and standards.  All samples were tuned and matched to 50 Ω resistive impedance 
before calibrating the 90° pulse to ¼ of the 360° pulse length determined from the null 
signal.  The 360° pulse value was used during the calculations to correct the 
measurements for probe damping [31]. All other conditions for the NMR spectra were the 
same as for the spectra acquired for purity assessment.  The spectra were processed in the 
same way as for the purity spectrum except that the integration was done with constant 
scaling between the spectra.   
 
Preparation of NRC CRM AZA1, -2 and -3 
Quantitative results from QNMR analysis were used to determine the amount of 
stock solution required for the production of NRC CRM-AZA1, -2 and -3. Stock 
solutions containing 1.47 µM of AZA1 (MW= 842.0845), 1.52 µM of AZA2 (MW = 
856.1072 g/mole) and 1.37 µM of AZA3 (MW = 828.0534 g/mol) were prepared, based 
on the density of CD3OH of 0.866 g/mL (at 23oC). Solutions were weighed in screw-cap 
vials and then transferred quantitatively into pre-weighed calibrated volumetric flasks. 
The flask for each AZA was filled to the mark with degassed high purity MeOH (Burdick 
and Jackson, CA, high purity solvent).  Care was taken to avoid turbulent mixing of the 
solvent with oxygen from the air. The final solution was weighed and sealed to prevent 
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evaporation. The solution was kept cool with ice during ampouling operations. All 
ampoules were washed with MeOH and dried prior to use. Ampoules were purged with 
Argon and then filled with 510 μL of the prepared CRM solution, and flame-sealed using 
an ampouling machine (Cozzoli Model FPS1-SS-428).  The ampoules were removed 
from the machine, inspected and labeled in sequential order.  
 
LC-MS quantification for homogeneity and stability studies 
All analytical LC-MS experiments were performed on an Agilent 1100 system 
coupled to an API 4000 triple-quadrupole system (Applied Biosystems/MDS Sciex) 
equipped with an electro spray ionization interface (ESI).  The API 4000 instrument was 
used with and ion spray voltage (IS) of 5500, a declustering potential (DP) of 60 V, a 
collision energy (CE) of 55 eV and a source temperature of 275 ºC.  Multiple reaction 
monitoring (MRM) experiments were carried out in positive ion mode by selecting the 
following transitions (precursor ion > fragment ion): (i) AZA1: m/z 842.5 > 672.5; (ii) 
AZA2: m/z 856.5 > 672.5 and (iii) AZA3: m/z 828.5 > 658.5.  A binary mobile phase 
was used, with (A) water and (B) 95% aqueous ACN, each containing 2 mM ammonium 
formate and 50 mM formic acid. A Hypersil BDS C8 column (50 mm × 2.1 mm i.d., 3 
μm) (Thermo Fisher Scientific, Loughborough, U.K.) was eluted isocratically with 70% 
B for 15 min. Retention times for AZA3, -1, and -2 were ca. 6.9, 9.5, and  11.5 min, 
respectively. 
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Results and discussion 
Isolation of AZAs 
 
Azaspiracids were isolated from contaminated blue mussels (Mytilus edulis) 
according to the extraction and isolation procedure summarized in Figure 2.  The 
recovery of individual components at each step in the isolation procedure are reported  in 
Figure 3.  Briefly, extraction of approximately 500 g of mussel HP with EtOH in 
triplicate yielded an extraction efficiency of 90%. Although the extraction efficiency 
could have been increased by additional extraction replicates, this would have introduced 
undesired matrix compounds that would have to be removed at a later stage. It was 
therefore decided that an extraction efficiency of 90% was sufficient for purification 
work.    
 Liquid-liquid-partitioning steps did not result in any significant toxin losses with 
recoveries nearing 95% (Fig. 3).  Partitioning with EtOAc readily formed emulsions 
when used with pure deionised water, likely due to the high lipid content of the mussel 
tissue.  The use of a 1 M NaCl solution instead of pure water prevented the formation of 
an emulsion and increased the effectiveness of this step. The hexane partitioning typically 
did not form any emulsions and separation was achieved rapidly.  
While liquid-liquid partitioning typically did not result in any significant toxin 
losses, chromatography on silica gel led to a noticeable loss (Fig. 3). Previous trials using 
gravity flow chromatography on slightly more coarse silica material (silica 60, Merck) 
with 100% acetone followed by 100% MeOH yielded a toxin recovery of only 35%. This 
loss could have been due to irreversible absorption of the toxin to the stationary phase. 
This step however, significantly improved purity so measures to minimize the loss were 
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preferable to replacing or omitting it from the procedure. Use of a vacuum setup rather 
than gravity flow reduced the time the compounds spent on the column. The use of a 
smaller particle size silica gel and a multiple step gradient increased toxin recovery to 
75%. Chromatography on silica gel with the described parameters removed over 90% of 
the loaded sample weight. This efficient clean-up justified the loss of 25% of AZAs 
during the procedure.   
Chromatography on Sephadex LH-20 also yielded high clean-up efficiency 
(removal of 75% of sample mass) and resulted in high recoveries of ca. 95%. 
Chromatography on C8 material by flash-chromatography did result in a 25-30% loss of 
toxin, although most of this was due to dissolution problems during the loading of the 
column. The use of a large amount of solvent to load the column in order to achieve 
complete dissolution resulted in peak broadening, and reduced the clean-up effect of the 
column. It was therefore decided to dissolve as much as possible with the maximum 
amount of solvent allowing for good chromatography and to store the undissolved 
remainder of the sample at –20 °C to be used in future purification work.   
The final purification step was carried out on a preparative LC-MS system, which 
facilitated automatic mass-directed fraction collection. This technique proved to be very 
helpful in correct identification of collected fractions during collection and also 
significantly increased sensitivity of detection in comparison to a UV or PDA detector. 
The low absorbance of AZAs due to the lack of a chromophore within the molecule 
requires monitoring of the substances at a wavelength near 200 nm when using UV 
detection. This can result in misidentification of peaks in the spectrum and can lead to 
contamination of the collected fractions. Use of a buffer during this step was necessary 
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for separation and better peak shape. However, it was observed that strong buffer 
concentrations and/or longer periods of exposure of AZAs to acidic buffer can lead to 
rearrangement reactions, resulting in the production of different toxin diastereomers. The 
concentrations of formic acid and ammonium formate were therefore kept to a minimum 
and the buffer components were removed from the isolated toxin within the shortest 
possible time period by  EtOAc partitioning.  The low concentration of buffer resulted in 
some tailing of peaks and in order to prevent overlap, only 20-30 μg of AZAs were 
injected per run. This part of the procedure proved to be the most labour intensive. While 
all other steps took between 3 and 10 hours, many replicate injections (>150) were 
needed for the final purification. The use of the Agilent preparative LC-MS system 
facilitated automation of this step and enabled up to 30 injections per day.  Collection of 
only the center of peaks (heart-cut) to ensure high purity of the target compound resulted 
in some loss of toxin during this step although the recovery of  the AZAs using this 
column material was established at 95%.  During this stage 3.3 mg of AZA1, 0.67 mg of 
AZA2 and 1.59 mg of AZA3  were obtained in high purity using the isolation procedure 
shown in Figure 2.  
 
Structural confirmation and purity assessment 
NMR spectroscopy was used to confirm the identity and purity of the AZAs by 
comparing spectra to literature chemical shift values.  Tandem mass spectrometry was 
also employed to obtain product ion scans to confirm the AZA structures.  Accurate 
masses were obtained on a quadrupole/time-of-flight mass spectrometer, and all 
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measured masses were found to be within 5 ppm (0.002 Da) of the theoretical 
monoisotopic masses.  
LC-MS was employed to estimate the purity of the AZA stock solutions.  Firstly, 
full spectrum data was acquired to identify potential impurities, and then single ion 
monitoring was employed to obtain maximum sensitivity to estimate the abundance of 
low-level impurities.   Several low-abundance impurities were identified, many of which 
appeared to be structural isomers of the AZAs (Fig 4).  These impurities are generally 
well resolved chromatographically from AZA1,-2, and 3, and are present at less than 1 % 
relative abundance to the AZAs. 
 
Characterization   
Accurate quantification of the AZAs in a CD3OH stock solution at the mM-level 
was performed by quantitative 1H-NMR [31], using external calibration with USP-grade 
caffeine.  1H-NMR is inherently a quantitative technique and yields equal response (area 
of resonances vs concentration) for all protons in a molecule.  These precise 
measurements require an in-depth knowledge of the structural assignments of chemical 
shifts, as the number of protons assigned to each group of resonances in the spectra must be 
known.  The procedures have been validated by cross-comparison of gravimetrically 
prepared solutions of USP-certified standard compounds (caffeine, theophylline, arginine 
and sucrose) [31] and have been successfully applied to the quantification of other 
phycotoxins such as domoic acid and okadaic acid.  
 Although typical characterization of CRMs employs at least two orthogonal 
methods for quantification, only one method was used in this case as no other definitive 
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methods were available.  Gravimetric analysis is generally not accurate for marine toxin 
quantification as it cannot allow for impurities such as salts, which is unavoidable for the 
extremely small quantities of toxin material isolated from contaminated shellfish.  Liquid 
chromatography coupled to chemiluminescence nitrogen detection (LC-CLND) was 
investigated as a potential definitive method for of AZAs, but sensitivity was insufficient for 
accurate quantification.  Although CLND has been implemented successfully for paralytic 
shellfish poisoning (PSP) toxins and domoic acid [32], the lone nitrogen atom of the AZAs 
coupled with their larger structure relative to PSPs or domoic acid, results in a significantly 
reduced mole fraction of nitrogen for the AZAs.  In addition to CLND, fluorescence 
derivatization methods were also attempted but did not generate quantitative results.  
Therefore, given the high demand for AZA calibration solutions due to the potential risk 
AZAs pose to food safety and increasing use of LC-MS for regulatory programs, only one 
method was employed for their characterization.          
 
Homogeneity Study  
The within- and between-bottle homogeneity was studied following the 
production of each material. The homogeneity testing protocol was developed from the 
recommendations of Ellison et al. [33]. For each of the AZA CRMs, approximately 3n1/3 
(n; total number of ampoules) of all ampoules produced were selected from over the 
entire ampoule range. The ampoules were randomly selected and AZA1, -2 and -3 were 
measured by LC-MS in MRM mode.  The between-bottle variation was measured to be 
less than 2.5%, no greater than the variation for replicate analyses of one solution, thus 
demonstrating acceptable homogeneity over the entire ampoule range.   
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Stability Study  
  To evaluate the stability of the calibration solutions during potential transport and 
storage, individual short-term and long-term stability studies were carried out.  In both 
cases, the isochronous stability study approach was employed, whereby samples are 
subjected to the test condition of interest at the appropriate interval to allow for 
simultaneous analysis of all samples in order to minimize analytical variability [34]. 
Temperatures studied were  -12ºC, 4ºC, 20ºC, and 37ºC, and data at these temperatures 
were compared to a reference temperature of -80ºC.   
For the short-term stability study, the calibration solutions were stored for 7, 10, 
15 and 30  days and then analyzed in the same batch over a 24-h period by LC-MS.  As 
shown in Figure 5a, results for AZA1 and AZA2 showed that no significant variation of 
concentration occurred over the range of temperatures during the 30-day period. 
However, AZA3 proved to be least stable of the three compounds, with significant 
degradation of 20% occurring at 37ºC after 10 days and roughly 50% after 30 days.  For a 
statistical assessment of the stability, the slope of the regression lines were tested for 
significance using the Student t-test, whereby texp = b/ub (where b is the slope of the 
regression line and ub is the standard error of the slope) obtained from analysis of 
variance (ANOVA) is compared to the t-statistic (ttab),with a 95% confidence level and n-
2 degrees of freedom [35]. Using this approach, the slope is considered insignificant and 
a material is deemed stable when texp is lower than ttab [35].   With the exception of AZA3 
at 37 ºC, all slopes of the stability plots for the short-term study were insignificant.  As 
the AZA calibration solutions will be shipped with refrigerants that have been shown to 
keep the contents of the insulated shipping container near 0ºC for up to 96 h, 37 ºC would 
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likely represent the worst case scenario for a lengthy delay in shipping.  Therefore, these 
results indicate that the AZA calibration solutions demonstrate reasonable short-term 
stability, and are suitable for transport under the appropriate conditions.    
The calibration solutions were stored for 30, 90, 180, and 360 days for the long-
term stability study before analysis by LC-MS.  As shown in 5b, AZA1 and AZA2 were 
over 90% degraded after 360 days at 37ºC, and less than 20% loss was observed at room 
temperature over this period.  AZA3 exhibited the greatest amount of degradation, with 
roughly 40% loss occurring after 360 days at room temperature and nearly 90% after 180 
days at 37ºC. This was in accordance with previous findings by McCarron et al. [10, 36].   
Unfortunately, due to ampoules being misplaced over the course of this study, no stability 
data was obtained beyond 180 days at 4ºC.  Regardless, -12ºC was chosen as the 
recommended storage temperature as conventional laboratory freezers are generally 
available in most laboratories.  No significant degradation was observed for any of the 
AZAs at -12ºC during this period of study and this was confirmed by testing the slopes 
for significance as described above [35]. Therefore, these data show that the AZAs are 
sufficiently stable for use as certified calibration solutions if stored at the recommended 
storage temperature of -12ºC or lower.   
 
Estimation of uncertainty  
The overall uncertainty estimate of the CRM (UCRM) is composed of individual 
uncertainties associated with the batch characterisation (uchar), uncertainty related to 
possible between-bottle variation (ubb), as well as uncertainty related to potential 
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instability due to long-term storage (ults) [35].   Using a coverage factor, K,   these 
components can be combined according to Equation 1.: 
 
 
2
lts
2
bb
2
charCRM     K   U uuu ++= (1) 
 
Values for the individual contributions to the overall uncertainty are listed in 
Table 1.  For uhar, standard deviations of the quantification data was used to estimate of 
the uncertainty.  The primary source of error in this case was the variability of the 
quantitative NMR measurements, with error associated with glassware and pipetting 
contributing to a lesser extent.   
To estimate ubb, ANOVA results from the homogeneity data were used to 
calculate the variation between bottles, Sbb,  according to Equation 2: 
    
       
with MSbetween being the mean squares between groups, MSwithin the mean squares within 
groups and n the number of replicates per ampoule.  The maximum between-ampoule 
variability u*bb was calculated using Equation 3:  
           
       
 
with עMSwithin  being the degrees of freedom of MSwithin [37]. The uncertainty of 
between-unit homogeneity (u ) is given by the larger value obtained from either u*  or 
S . The estimated value for u*  was found smaller than S  for AZA1, -2 and -3, 
bb bb
bb bb bb
n
MS -MS
  S withinbetweenbb = (2) 
4bb
n
 νu MS
within*
within
2MS = (3) 
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therefore S   was subsequently used as an estimate for bb ubb.  The resulting values for ubb 
are listed in Table 1.
 Although both short-term and long-term stability studies were carried for the 
AZA calibration solution, typically only the uncertainty of long-term stability associated 
with storage is included in the certified uncertainty [35].  As described above, although 
the knowledge of the stability during transport is crucial, shipping conditions must be 
chosen such that the uncertainty due to instability is negligible [35].     The uncertainty 
due to long-term storage (ults) can be estimated by ults = ub xshelf life, where ub is the 
standard error of the slope of the stability curve at the recommended storage temperature 
(-12ºC) and xshelf life is the shelf-life of the reference material [35].  In our case, ub  was 
obtained directly from the ANOVA results used to assess stability (see above) and the 
shelf-life employed was 365 days.  The uncertainties associated with long-term storage 
for the AZA calibration solutions are summarized in Table 1.     
 
Certified values  
Using a coverage factor of 2, the certified values of AZA1, -2 and -3 were 
determined to be 1.47 ± 0.08 μmol/L, 1.52  ± 0.05 μmol/L, and 1.37  ± 0.13 μmol/L, 
respectively, as summarized in Table 2.  These concentration levels are suitable for their 
intended use, primarily the calibration of LC-MS instrumentation.  Although significantly 
lower in concentration than most other marine toxin certified reference materials, AZAs 
generate stronger response than most toxins in MS by electrospray ionization (ESI) in 
positive mode, due to the presence of the amine group in the AZAs’ structure.      
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Conclusions 
AZA1,-2 and -3  were purified in sufficient amounts and purity to produce CRMs. 
Approximately 3600 ampoules containing 0.5 mL of a 1.47 μM solution of AZA1, 988 
ampoules of a 1.52 μM solution of AZA2 and 1960 ampoules of 1.37 μM solution of 
AZA3 were prepared. A purification procedure was developed that yielded sufficient  
AZA recoveries for effective isolation of AZAs from contaminated mussel tissue. 
Quantitative NMR techniques were used to accurately certify the concentration of the 
calibrations solutions. The solutions were shown to be homogeneous and sufficiently 
stable for use as certified calibration solutions if stored at the recommended conditions of 
-12ºC.  In addition to these calibration solutions, the NRC Certified Reference Materials 
Program (CRMP) is currently developing a mussel tissue CRM with certified values for 
AZA1, -2, and -3. 
 
Acknowledgements 
The authors would like to thank all members of the NRC Certified Reference 
Materials Program for assistance with ampouling the AZA calibration solutions. Funding 
for materials retrieval and isolation of AZAs was provided by the Irish National 
Development Plan through the ASTOX project (ST/02/02, 2003–2007), and the ASTOX2 
project (Irish National Development Plan 2007 – 2013, grant number 
PBA/AF/08/001(01)). 
 21
References  
 
1. McMahon T, Silke J (1996) Winter toxicity of unknown aetiology in mussels. 
Harmful Algae News 14 
2. McMahon T, Silke J (1998) Re-occurrence of winter toxicity. Harmful Algae 
News 17 
3. Satake M, Ofuji K, James K, Furey A, Yasumoto T (1998) New toxic event 
caused by Irish mussels. In: Reguera B BJ, Fernandez ML, Wyatt T (ed) Harmful Algae. 
Santiago de Compostela; Xunta de Galicia and Intergovernmental Oceanographic 
Commission of UNESCO, p 2 
4. Satake M, Ofuji K, Naoki H, James KJ, Furey A, McMahon T, Silke J, Yasumoto 
T (1998) Azaspiracid, a new marine toxin having unique spiro ring assemblies, isolated 
from Irish mussels, Mytilus edulis. Journal of the American Chemical Society 120:9967-
9968 
5. Ofuji K, Satake M, McMahon T, Silke J, James K, Naoki H, Oshima Y, 
Yasumoto T (1999) Two analogs of azaspiracid isolated from mussels, Mytilus edulis, 
involved in human intoxication in Ireland. Nat Toxins 7:4 
6. James KJ, Sierra MD, Lehane M, Magdalena AB, Furey A (2003) Detection of 
five new hydroxyl analogues of azaspiracids in shellfish using multiple tandem mass 
spectrometry. Toxicon 41:277-283 
7. Rehmann N, Hess P, Quilliam MA (2008) Discovery of new analogs of the 
marine biotoxin azaspiracid in blue mussels (Mytilus edulis) by ultra-performance liquid 
 22
chromatography/tandem mass spectrometry. Rapid Communications in Mass 
Spectrometry 22:549-558 
8. Tillmann U, Elbrachter M, Krock B, John U, Cembella A (2009) Azadinium 
spinosum gen. et sp nov (Dinophyceae) identified as a primary producer of azaspiracid 
toxins. European Journal of Phycology 44:63-79 
9. Krock B, Tillmann U, John U, Cembella AD (2009) Characterization of 
azaspiracids in plankton size-fractions and isolation of an azaspiracid-producing 
dinoflagellate from the North Sea. Harmful Algae 8:254-263 
10. McCarron P, Kilcoyne J, Miles CO, Hess P (2009) Formation of Azaspiracids-3,-
4,-6, and-9 via Decarboxylation of Carboxyazaspiracid Metabolites from Shellfish. 
Journal of Agricultural and Food Chemistry 57:160-169 
11. Amzil Z, Sibat M, Royer F, Savar V (2008) First report on azaspiracid and 
yessotoxin groups detection in French shellfish. Toxicon 52:39-48 
12. Furey A, Moroney C, Magdalena AB, Saez MJF, Lehane M, James KJ (2003) 
Geographical, temporal, and species variation of the polyether toxins, azaspiracids, in 
shellfish. Environmental Science & Technology 37:3078-3084 
13. Magdalena AB, Lehane M, Krys S, Fernandez ML, Furey A, James KJ (2003) 
The first identification of azaspiracids in shellfish from France and Spain. Toxicon 
42:105-108 
14. Twiner MJ, Rehmann N, Hess P, Doucette GJ (2008) Azaspiracid shellfish 
poisoning: A review on the chemistry, ecology, and toxicology with an emphasis on 
human health impacts. Marine Drugs 6:39-72 
 23
15. Vale P, Bire R, Hess P (2008) Confirmation by LC-MS/MS of azaspiracids in 
shellfish from the Portuguese north-western coast. Toxicon 51:1449-1456 
16. Taleb H, Vale P, Amahir R, Benhadouch A, Sagou A, Chafik R (2006) First 
detection of azaspiracids in mussels in North West Africa Journal of Shellfish Research 
25:1067-1070 
17. European Food Safety Authority Marine biotoxins in shellfish - Azaspiracid 
group, Scientific Opinion of the Panel on Contaminants in the Food chain (2008). EFSA 
Journal 723:1-52 
18. Ito E, Satake M, Ofuji K, Kurita N, McMahon T, James K, Yasumoto T (2000) 
Multiple organ damage caused by a new toxin azaspiracid, isolated from mussels 
produced in Ireland. Toxicon 38:917-930 
19. Ito E, Satake M, Ofuji K, Higashi M, Harigaya K, McMahon T, Yasumoto T 
(2002) Chronic effects in mice caused by oral administration of sublethal doses of 
azaspiracid, a new marine toxin isolated from mussels. Toxicon 40:193-203 
20. Ito E, Frederick MO, Koftis TV, Tang WJ, Petrovic G, Ling TT, Nicolaou KC 
(2006) Structure toxicity relationships of synthetic azaspiracid-1 and analogs in mice. 
Harmful Algae 5:586-591 
21. Twiner MJ, Hess P, Dechraoui MYB, McMahon T, Samons MS, Satake M, 
Yasumoto T, Ramsdell JS, Doucette GJ (2005) Cytotoxic and cytoskeletal effects of 
azaspiracid-1 on mammalian cell lines. Toxicon 45:891-900 
22. Twiner MJ, Ryan JC, Morey JS, Smith KJ, Hammad SM, Van Dolah FM, Hess P, 
McMahon T, Satake M, Yasumoto T, Doucette GJ (2008) Transcriptional profiling and 
 24
inhibition of cholesterol biosynthesis in human T lymphocyte cells by the marine toxin 
azaspiracid. Genomics 91:289-300 
23. Hess P, Butter T, Petersen A, Silke J, McMahon T (2009) Performance of the EU-
harmonised mouse bioassay for lipophilic toxins for the detection of azaspiracids in 
naturally contaminated mussel (Mytilus edulis) hepatopancreas tissue homogenates 
characterised by liquid chromatography coupled to tandem mass spectrometry. Toxicon 
53:713-722 
24. Risk Assessment of Azaspiracids in Shellfish: A report of the Scientific 
Committee of the Food Safety Authority of Ireland (2006), http://www.fsai.ie.:39 pages 
25. Regulation (EC) Nº 853/2004 of the European Parliament and of the Council of 
29 April 2004 laying down specific hygiene rules for on the hygiene of foodstuffs. 
Official Journal of the European Union L 139/55 
26. DG Sanco (EU Directorate General for Consumer Health and Protection). Report 
of the meeting of the Working Group on Toxicology of DSP and AZP, 21 to 23rd May 
2001, Brussels.  
27. ISO/IEC 17025:2005 General requirements for the competence of testing and 
calibration laboratories. 2nd edn. International Organizaiton for Standardization (ISO) 
,Geneva, Switzerland 
28. ISO Guide 33 (2000)  Uses of certified reference materials. International 
Organizaiton for Standardization (ISO) ,Geneva, Switzerland 
29. ISO Guide 34 (2000)  General requirements for the competence of reference 
material producers. International Organizaiton for Standardization (ISO) ,Geneva, 
Switzerland 
 25
30. ISO Guide 35 (1989)  Certification of reference materials-General and statistical 
principles. International Organizaiton for Standardization (ISO) ,Geneva, Switzerland 
31. Burton I, Quilliam MA, Walter JA (2005) Quantitative 1H NMR with External 
Standards: Use in Preparation of Calibration Solutions for Algal Toxins and Other 
Natural Products. Analytical Chemistry 77:3123-3131 
32. Quilliam MA, Wechsler D, Fraser H (2003) Analysis of Natural Toxins by Liquid 
Chromatography and Chemiluminescent Nitrogen Detection.  HABTech 2003 Workshop, 
Nelson, New Zealand, pp 103-106 
 
33. Ellison S.R.L. BS, Walker R.F., Heydom K., Månsson M., Pauwels J., 
Wegscheider W.,  Nijenhuis B te (2001) Uncertainty for reference materials certified by 
interlaboratory study: Recommendations of an international study group. Accred Qual 
Assur 6:274-277 
34. Linsinger T. VdVA, Gawlik B., Pauwels J. and Lamberty A. (2004) Planning and 
combining of isochronous stability studies of CRMs. Accred Qual Assur 9:464-472 
35. Linsinger T. PJ, Lamberty A., Schimmel H. ,Van der Veen H. ,  Siekmann L . 
(2001) Estimating the uncertainty of stability for matrix CRMs. Fresenius. J. Anal. Chem 
370:183-188 
36. McCarron P, Emteborg H, Hess P (2007) Freeze-drying for the stabilisation of 
shellfish toxins in mussel tissue (Mytilus edulis) reference materials. Analytical and 
Bioanalytical Chemistry 387:2475-2486 
 26
37. Ciardullo S.  HA, D'Amato M.,  Emons H.  and Caroli S. (2005) Homogeneity 
and stability study of the candidate reference material Adamussium colbecki for trace 
elements. J. Environ. Monit. 7:1295-1298 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 27
Figure Captions 
 
Figure 1. Structures of the three predominant azaspiracids. AZA1 (R1 = H, R2 = H, 
R3=CH3); AZA2 (R1 =H, R2= CH3, R3= CH3); AZA3 (R1= H, R2 =H, R3 =H). 
 
Figure 2.  Schematic of the isolation procedure used for the production of CRM-AZA1, 
AZA2 and AZA3. 
 
Figure 3. Comparision of the % recovery of individual isolation steps for the reported 
extraction and isolation procedure.  
 
Figure 4. LC/MS analysis of NRC CRM AZA1, AZA2 and AZA3 using MRM at m/z 
842.5>672.5, 856.5>672.5 and 828.5>658.5 respectively.  
 
Figure 5.  Short-term (a) and long-term (b) stability study data for AZA1, AZA2 and 
AZA3 at  -12ºC, 4ºC, room temperature (RT; ~ 20ºC), and 37ºC. 
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 Table 1.  Uncertainty components for AZA1, AZA2 and AZA3 
 
 
 
Uncertainty 
component 
AZA1 
(µmol/L) 
AZA2 
(µmol/L) 
AZA3 
(µmol/L) 
uchar 0.02 0.02 0.05 
ubb 0.03 0.01 0.01 
ults 0.02 0.01 0.04 
UCRM (k=2)   0.08 0.05 0.13 
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Table 2. Certified concentrations for AZA1, AZA2 and AZA3 
 
 
 
 Analyte Certified concentration 
(µmol/L) 
AZA1    1.47   ± 0.08 
AZA2   1.52   ± 0.05 
AZA3 1.37   ± 0.13 
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